Showing results (41-50 of 124) with videos related to
Sort By:
Pageof 13
Clinical Colorectal Cancer|June 9, 2021
Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials GroupCatherine Dunn, Wei Hong, Peter Gibbs, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 22, 2026
International practice patterns and perceptions of pressurised intraperitoneal aerosol chemotherapy for management of gastric cancer: A global clinician surveyHarleen Kaur, Tharindie N Silva, Josephine A Wright, et al.Expert Review of Anticancer Therapy|June 6, 2025
The current landscape of neoadjuvant therapy for resectable colon cancerMei Chan, Tharani Krishnan, Amanda Townsend, et al.Patient Education and Counseling|May 25, 2021
The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosisLisa Guccione, Karla Gough, Allison Drosdowsky, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2023
The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosisLisa Guccione, Karla Gough, Allison Drosdowsky, et al.Clinical Colorectal Cancer|May 13, 2026
Late-line Systemic Therapy in Metastatic Colorectal Cancer: A Narrative Review and Australian Expert PerspectiveMatthew Burge, Jeanne Tie, Tharani Krishnan, et al.Annals of Surgery|February 8, 2017
Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Patients With Indeterminate Extrahepatic Disease on 18FDG-PET Scan Before Liver Resection for Metastatic Colorectal CancerGeoffrey Yuet Mun Wong, Rajiv Kumar, Carol Beeke, et al.Pleura and Peritoneum|April 25, 2025
Pressurised intraperitoneal aerosol chemotherapy (PIPAC): the first Australian experienceKatarina Foley, Jessica Reid, Suzanne Edwards, et al.Cancer Treatment Reviews|December 13, 2023
Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: Current strategies and future challengesCeline Man Ying Li, Runhao Li, Paul Drew, et al.Clinical Colorectal Cancer|July 6, 2012
Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancerMuhammad A Khattak, Hilary L Martin, Carol Beeke, et al.Pageof 13